Oxford Lane Capital has set December 4 as the date it will retire the last of its 5.00% notes due 2027, a $40 million principal repayment that gives shareholders a fixed marker against which to weigh a softer distribution and a thinner yield from the firm’s CLO equity holdings.
The redemption covers every remaining note of the issue at $25 per note, plus accrued and unpaid interest. Once settled, the securities will be delisted from the Nasdaq, closing out both the outstanding principal and the listing.
Word of the repayment came Wednesday, alongside quarterly figures that showed pressure on both the income side and the underlying portfolio. Investment income for the quarter totaled $82.2 million, down roughly $4.8 million from the immediately preceding quarter. GAAP net investment income came in at $47.8 million, or $0.49 per share, while Core NII β the company’s own adjusted measure β reached $66.4 million, or $0.68 per share.
The more closely watched gauge for Oxford Lane is the weighted average cash distribution yield on its CLO equity investments, which fell to 12.4% from 16.3%. That figure tracks the payouts generated by the portfolio’s holdings, not the yield on Oxford Lane’s own stock. A rebound would ease the flow of cash into the company; another leg lower would sharpen the strain on its ability to fund distributions.
Should investors sell immediately? Or is it worth buying Oxford Lane Capital?
Net asset value per share also retreated, to $9.95 from $10.74, a decline that points to weakening substance behind the portfolio if it continues.
On the payout side, Oxford Lane declared monthly distributions on its common stock of $0.10 per share for January through March 2027 β half the prior $0.20 monthly rate. The cut could work in the company’s favor, leaving more capital inside the business and giving it room to reconcile distributions with capital preservation, provided earnings hold up. Should the cash yield from the CLO equity book keep sliding, the smaller payment would offset only part of the earnings pressure, and management would need to show improvement in the investment portfolio itself to make any stabilization stick.
For holders, the equation now runs on two tracks: whether earnings and cash flows can carry the reduced distribution on a lasting basis, and whether the December redemption clears the way for a firmer footing. A steadying in yields alongside the lower payout would offer relief from both directions. A continued drop in earnings and net asset value would undercut that case. The distribution declared for early 2027, and the December 4 note redemption, are the next fixed points to watch.
Ad
Oxford Lane Capital Stock: Buy or Sell?! New Oxford Lane Capital Analysis from November 9 delivers the answer:
The latest Oxford Lane Capital figures speak for themselves: Urgent action needed for Oxford Lane Capital investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 9.
Oxford Lane Capital: Buy or sell? Read more here...
